+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

PRINTER FRIENDLY

Global Mergers and Acquisitions (M&A) Deals in Q3 2021 - Top Themes in the Medical Devices Sector - Thematic Research

  • ID: 5460100
  • Report
  • October 2021
  • Region: Global
  • 26 Pages
  • GlobalData
1h Free Analyst Time
1h Free Analyst Time

Speak directly to the analyst to clarify any post sales queries you may have.

FEATURED COMPANIES

  • 22C Capital
  • Bioventus
  • EQT Partners
  • ICU Medical
  • Longview acquisition
  • Omniome
1h Free Analyst Time

Speak directly to the analyst to clarify any post sales queries you may have.

Global Mergers and Acquisitions (M&A) Deals in Q3 2021 - Top Themes in the Medical Devices Sector - Thematic Research

Summary


This report analyzes the disruptive themes that have driven M&A activity in Q3 2021 in Medical Devices Sector.

M&A deals in Q3 2021 recorded a drop of 38% in deal value (to $52 billion) and 18% in deal volume terms, compared to the previous quarter. However, when compared to the deal activity in Q3 2020, both deal value and volume were consistent.

Scope


  • This report provides an overview of merger and acquisition activity globally in Q3 2021 in Medical Devices Sector.
  • It identifies the themes driving most notable to deals announced in Q3 2021 in the Medical Devices Sector.

Reasons to Buy


  • Companies who invest in the right themes become success stories; those who miss the big themes end up as failures. If you want to understand the themes that drive an industry, simply look at the list of recent mergers and acquisitions (M&A).
  • In this report we have listed down the most notable deals in Medical Devices sector to make it easy for our clients to get a view of themes disrupting the sector and prepare for the future.
Note: Product cover images may vary from those shown

FEATURED COMPANIES

  • 22C Capital
  • Bioventus
  • EQT Partners
  • ICU Medical
  • Longview acquisition
  • Omniome
  • Global M&A deals in Q3 2021 - Key takeaways
  • Review of global M&A deals in Q3 2021
  • Themes driving global M&A deals in Q3 2021
  • Appendices
Note: Product cover images may vary from those shown

A selection of companies mentioned in this report includes:

  • Sigma Healthcare
  • Australian Pharmaceutical
  • GE Healthcare
  • BK Medical Systems
  • Boston Scientific
  • Devoro Medical
  • Mesa Laboratories
  • Agena Bioscience
  • Agiliti Health
  • Sizewise Rentals
  • Zoll Medical
  • Itamar Medical
  • ICU Medical
  • Smiths Group
  • planmeca Verwaltungs
  • Envista
  • Cardio Partners
  • Allied 100
  • Baxter
  • Hill-Rom
  • Nordic Capital
  • 22C Capital
  • Insight Partners
  • Inovalon
  • Hibercell
  • Genuity Science
  • Nano-X Imaging
  • Zebra Medical Vision
  • Medtronic
  • Intersect ENT
  • Trulli Bidco
  • Smiths Medical
  • Bioventus
  • Misonix
  • Surgical Science
  • Simbionix
  • EQT Partners
  • Lifebrain
  • Pacific Biosciences of California
  • Omniome
  • HeartFlow
  • Longview acquisition
Note: Product cover images may vary from those shown